Full Event Guide

5th International Cannabinoid-Derived Pharmaceuticals Summit

The 5th International Cannabinoid-Derived Pharmaceuticals Summit is uniting drug developers around the globe working on the complex production of plant-based, biosynthetic, and synthetic endocannabinoid system modulators. 35+ expert speakers will lead sessions on critical topics such as overcoming the human evidence gap, sourcing high-quality cannabinoids and testing under rigorous regulatory requirements across 3 days of presentations, panel discussions and interactive workshops in Boston. The Summit focuses on the real science in the cannabinoid industry and is the only chance to connect with likeminded, analytical professionals looking to move the dial forward in this exciting space.

Screenshot 2022-08-09 143306

Agenda highlights:

  • Present a poster of your drug development pipeline at our investor networking session, and connect with the decision makers looking to fund promising cannabinoid therapeutics
  • Get the most up-to-date regulatory perspectives from the FDA and other organizations with Dominic Chiapperino (FDA) and Cassie Taylor
    (FDA)
  • Produce and source high-purity cannabinoids from synthetic, plant-based and biosynthetic sources with Purisys, Kinetochem and our other world-leading partners
  • Hear from the key opinion leaders at the forefront of next-generation cannabinoid-derived pharmaceutical development including Alistair Vickery (Emyria), Brian Murphy (Former CEO of Emerald Bioscience) and Jeff Chen (Radicle Sciences)
  • Streamline successful late-stage clinical trials and be the next one across the finish line with a multi-format and highly interactive session with Sud Agarwal (Cannvalate)
  • Join 2 half-day workshops – one dedicated to bridging the gap between OTC and prescribed pharmaceuticals, and an additional behind-the-scenes workshop on the psychedelics field, preparing you for exploration into a new area
  • 29+ case study-led presentations to facilitate better understanding of the drug development and cannabinoid production essential to this industry
  • Connect with 80+ thought leaders and industry peers as they come together to drive discussion and progress across the 3-day event

 

Download the full event guide above to access the full agenda